Loading…
Primary psychoactive alkaloid in Nymphaea caerulea. In vitro studies demonstrate dopamine antagonism in low micromolar concentrations. Animal models show CNS depression and anxiolytic-like effects. Research suggests potential antipsychotic properties (via dopamine antagonism) and neuroprotective effects (via sigma-1 activation), but human pharmacokinetics and bioavailability poorly characterized. Euphoric effects observed in traditional use may result from dopamine antagonism at low doses creating distinctive psychopharmacological state.
Anti-obesity and sedative effects in animal models; antiarrhythmic potential
Representative pattern: C₉H₇N₂O
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.